Background: This study investigates the therapeutic versus side effects of intranasal lithium chloride (LiCl) in Ryanodex formulation vehicle (RFV) to inhibit inflammation and pyroptosis and to ameliorate on cognitive dysfunction and depressive behavior in 5XFAD mice.
Method: 5XFAD and wild type (WT) B6SJLF1/J mice were treated with intranasal or oral LiCl (3 mM/kg) dissolved in RFV starting at 2 or 9 months old and the continuous treatment lasted for 12 weeks. Behavior was examined for depression, cognition, olfaction, and motor function at the ages of 5 or 12 months. Body weights were monitored monthly. At 6 or 13 months old, blood and brain were harvested. Blood biomarkers for thyroid (TSH: thyroid stimulating hormone) and kidney (creatinine) function were measured by ELISA. Immunoblotting determined the proteins expression levels of type 1 InsP receptors (InsPR-1), oxidative stress (4-HNE, MDA), pyroptosis activation pathway regulatory proteins, proinflammatory versus neuroprotective cytokines, and synaptic proteins in aged mice brains.
Result: Compared to WT mice, significant memory loss and depression behavior existed in both adult and aged 5XFAD mice, and both were abolished by intranasal LiCl in RFV Intranasal LiCl in RFV significantly inhibited the pathological proteins increase of InsPR-1, MDA-modified proteins by pyroptosis pathway activation proteins (NLRP3, cleaved caspase-1, N-terminal GSDMD) in aged 5XFAD mice brains, in comparison with aged WT mice brains. Furthermore, intranasal LiCl in RFV significantly reduced protein levels of cytotoxic cytokines (IL-1β, IL-18, IL-6, TNF-α), alleviated the activation of astrogliosis and microgliosis, and increased cytoprotective cytokine IL-10 and inhibited PSD-95 synapse protein loss in aged 5XFAD mice brain. Intranasal LiCl did not affect blood TSH but significantly inhibited abnormal age-dependent increase of blood creatinine in 5XFAD mice. Intranasal LiCl in RFV did not affect body weight, smell, or motor function significantly in either WT or 5XFAD mice.
Conclusion: Intranasal LiCl in RFV ameliorates memory loss and depressive behavior in 5XFAD mice without side effects or organ toxicity, with chronic use. Intranasal LiCl in RFV effectively inhibited, oxidative stress, inflammation and pyroptosis in aged 5XFAD brains.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.089654 | DOI Listing |
Alzheimers Dement
December 2024
Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, U.S.A., Philadelphia, PA, USA.
Background: This study investigates the therapeutic versus side effects of intranasal lithium chloride (LiCl) in Ryanodex formulation vehicle (RFV) to inhibit inflammation and pyroptosis and to ameliorate on cognitive dysfunction and depressive behavior in 5XFAD mice.
Method: 5XFAD and wild type (WT) B6SJLF1/J mice were treated with intranasal or oral LiCl (3 mM/kg) dissolved in RFV starting at 2 or 9 months old and the continuous treatment lasted for 12 weeks. Behavior was examined for depression, cognition, olfaction, and motor function at the ages of 5 or 12 months.
bioRxiv
December 2024
Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, U.S.A.
Pol J Vet Sci
March 2022
College of Veterinary Medicine, Hunan Agricultural University, Furong District, Nongda Road, No.1, Changsha 410128, China.
Porcine contagious pleuropneumonia (PCP) is a very serious respiratory disease which is difficult to prevent and treat. In this study, the therapeutic effects of lithium chloride (LiCl) on PCP were examined using a mouse model. A mouse model of PCP was established by intranasal infections with Actinobacillus pleuropneumoniae (App).
View Article and Find Full Text PDFVirology
October 2008
Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra, Majadahonda, Madrid, Spain.
The human respiratory syncytial virus (HRSV) structural P protein, phosphorylated at serine (S) and threonine (T) residues, is a co-factor of viral RNA polymerase. The phosphorylation of S54 is controlled by the coordinated action of two cellular enzymes: a lithium-sensitive kinase, probably glycogen synthetase kinase (GSK-3) beta and protein phosphatase 2A (PP2A). Inhibition of lithium-sensitive kinase, soon after infection, blocks the viral growth cycle by inhibiting synthesis and/or accumulation of viral RNAs, proteins and extracellular particles.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!